Tag: Clinical-Trial
-
-
Deep-Dive: Argatroban in Acute Ischemic Stroke With Early Neurological Deterioration — A 2023 RCT From China
-
Thrombus Migration After Tenecteplase Versus Alteplase in Acute Large Vessel Occlusion
-
Deep-Dive: Predictors of Hematoma Expansion and Response to Andexanet — ANNEXA-I Secondary Analyses
-
Deep-Dive: Argatroban Plus DAPT in Branch Atherosclerosis Disease — Halves END
-
Deep-Dive: JX10 — A Late-Window Anti-Inflammatory Thrombolytic Hits Phase 2a Safety Mark
-
Deep-Dive: ANNEXA-I Biomarker Substudy — Andexanet's Therapeutic Window Is 1 Hour, and It Cuts Both Ways
-
Deep-Dive: Perforator Territory Infarction Doubles 90-Day Disability Odds After LVO Thrombectomy
-
Deep-Dive: MR CLEAN M2 Registry — Bridging Therapy Edges Out Direct EVT for M2 Occlusions
-
Deep-Dive: ETLAS-2 — Tadalafil for CSVD Fails Feasibility, but the Imaging Signal Hints at a Better Trial